Graduate Theses, Dissertations, and Problem Reports
2011

Characterization and genetic manipulation of ergot pathway
inefficiency in fungi
Prashanthi Mulinti
West Virginia University

Follow this and additional works at: https://researchrepository.wvu.edu/etd

Recommended Citation
Mulinti, Prashanthi, "Characterization and genetic manipulation of ergot pathway inefficiency in fungi"
(2011). Graduate Theses, Dissertations, and Problem Reports. 3404.
https://researchrepository.wvu.edu/etd/3404

This Dissertation is protected by copyright and/or related rights. It has been brought to you by the The Research
Repository @ WVU with permission from the rights-holder(s). You are free to use this Dissertation in any way that is
permitted by the copyright and related rights legislation that applies to your use. For other uses you must obtain
permission from the rights-holder(s) directly, unless additional rights are indicated by a Creative Commons license
in the record and/ or on the work itself. This Dissertation has been accepted for inclusion in WVU Graduate Theses,
Dissertations, and Problem Reports collection by an authorized administrator of The Research Repository @ WVU.
For more information, please contact researchrepository@mail.wvu.edu.

Characterization and genetic manipulation of ergot
pathway inefficiency in fungi
Prashanthi Mulinti
Dissertation submitted to the
Davis College of Agriculture, Forestry, and Consumer Sciences
at West Virginia University
in partial fulfillment of the requirements
for the degree of

Doctor of Philosophy
in

Genetics and Developmental Biology

Daniel G. Panaccione, Ph.D., Chair
Jed H. Doelling, Ph.D.
Joseph B. Morton, Ph.D.
Christopher L. Schardl, Ph.D.
Jianbo Yao, Ph.D.

Division of Plant and Soil Sciences
Morgantown, West Virginia

2011

Keywords: Ergot alkaloids, GFP, A. fumigatus, Neotyphodium sp. Lp1, ergot pathway inefficiency, RNA
interference (RNAi), overexpression

Copyright 2011 Prashanthi Mulinti

ABSTRACT
Characterization and genetic manipulation of ergot pathway
inefficiency in fungi
Prashanthi Mulinti
Ergot alkaloids are mycotoxins that negatively affect humans and animals but also have useful
pharmaceutical properties. Ergot alkaloids have been extensively studied in Claviceps purpurea,
and also have been reported in other fungi, such as certain Penicillium spp., Aspergillus
fumigatus, and several Neotyphodium spp. that are endophytes of grasses. There is a high
degree of variation in the production of ergot alkaloids within an individual species and among
producers from different taxa, which means different fungi accumulate different profiles of ergot
alkaloids rather than a single pathway end product. These varied profiles result, in part, from
inefficiency in the pathway which leads to increased accumulation of certain pathway
intermediates in addition to the end product of the pathway. These intermediates have different
biological activities and provide different benefits to the host than the pathway end products. I
conducted a series of experiments to investigate the potential mechanisms by which fungi
accumulate different profiles of intermediates and end products. In A. fumigatus, efficiency in
completing the pathway varied developmentally. Wild type conidiating cultures containing all cell
types involved in conidiation (hyphae, vesicle of conidiophore, phialides of conidiophore, and
conidia) accumulated more of the pathway intermediate festuclavine and less of the pathway
end product fumigaclavine C than did isolated mature conidia. Such differences also were
indicated by studies with a medA mutant, which proliferates phialides. The medA mutant
accumulated more pathway intermediates than did the wild type or a complemented medA
mutant. A stuA mutant, lacking recognizable conidiophores, produced no detectable ergot
alkaloids. Although this variation in alkaloid accumulation indicated a difference in distribution or
activity of ergot pathway enzymes, fluorescence associated with the expression of five tested
alkaloid pathway genes indicated a similar pattern of expression of each gene in the different
cell types. Fluorescence was not observed in young hyphae but was detected at the apices of
hyphae as they swelled to form the vesicle of the conidiophore. More fluorescence was
observed in mature vesicles, phialides, and conidia. No qualitative differences were observed in
cell type-specific expression of different pathway genes, indicating that observed differences in
accumulation of intermediates versus end product must be due to quantitative differences in
expression or differences in activity of pathway enzymes. In Neotyphodium lolii × Epichloë
typhina isolate Lp1, an endophytic symbiont of perennial ryegrass, different ergot alkaloid
profiles were observed in different tissues of the host plant. RNA interference (RNAi) and overexpression of the easA gene genetically manipulated the flux of metabolites down the pathway.
When compared to wild type, knock-down of easA gene resulted in higher accumulation of a
pathway intermediate and a shunt product in comparison to pathway end product. In contrast,
over-expression of easA resulted in higher accumulation of the pathway end product and no
significant difference in the accumulation of intermediates and shunt products of the pathway.
Collectively, my results indicated that the efficiency of the ergot pathway varies at cellular level
in A. fumigatus and at the tissue level in Neotyphodium sp. Lp1. Also,in Neotyphodium sp. Lp1,
efficiency in the flow of intermediates down the ergot alkaloid pathway can be manipulated by
altering the expression of easA.
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Overview
Ergot alkaloids were first discovered in the sclerotia of the ergot fungus, Claviceps
purpurea. They are mycotoxins that exert toxic effects on humans and animals. While
ergot alkaloids are better known for their toxicity, they also have pharmaceutical
properties (Pertz and Eich, 1999; Tudzynski et al., 2001; Panaccione and Schardl,
2003). Ergot alkaloids have been extensively studied in C. purpurea, and are also
reported in other species, such as certain Penicillium spp., Aspergillus fumigatus, and
several epichloae (Epichloë and Neotyphodium spp.) that are endophytes of grasses
(Panaccione and Schardl, 2003; Schardl et al., 2006). There is a very high degree of
variation in the types of ergot alkaloids produced within an individual and among
producers from different taxa, which means different fungi accumulate different profiles
of ergot alkaloids rather than a single pathway end product. Some of the variation in
ergot alkaloid profiles results from inefficiency in the pathway which leads to
accumulation of the pathway intermediates (Panaccione, 2005). The pathway is
particularly inefficient in grass endophytes, which leads to high levels of intermediate
and by-product accumulation relative to the end product of the pathway. This pathway
inefficiency may be beneficial to the fungus because different ergot alkaloids have
different biological activities and thus, could play a major role in the survival of the
fungus.

Ergot alkaloids and their historical significance
Ergot alkaloids are a complex family of indole-derived mycotoxins with diverse biological
activities. They affect humans and livestock, and the extent of damage depends on
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various factors such as strength of the toxins, time of exposure, and the individual’s
health. These alkaloids typically affect the central nervous, immune, circulatory and
reproductive systems (Grocer and Floss, 1998; Pertz and Eich, 1999; Tudzynski et al.,
2001; Panaccione and Schardl, 2003). Historically, humans suffered from ergotism, also
known as the “Devils curse” or “St. Anthony’s fire,” upon consumption of grain
contaminated with sclerotia of the ergot fungus, Claviceps purpurea. The ergot alkaloids
retain their activity even after the contaminated grain has been made into bread
(Peraica et al., 1999). There are two distinct types of ergotism, gangrenous and
convulsive ergotism, based on the type of alkaloid involved. Gangrenous ergotism
results in gangrene of the limbs, and is usually caused by ergopeptine alkaloids,
because of their vasoconstrictive properties. Convulsive ergotism, which is more
typically caused by intoxication with ergot clavines or simple amides of lysergic acid, is
characterized by hallucinations, involuntary muscle contractions and gastrointestinal
problems. However, there is significant overlap in the types of symptoms induced by
different ergot alkaloid sources. Ergotism is now a rare occurrence because of various
precautions such as grain cleaning before milling which removes most of the alkaloids,
and crop rotation. The last documented outbreak of ergotism due to ergot clavines was
seen in India in 1975 (Peraica et al., 1999) and that due to ergotamine was reported in
Ethiopia in 1977 (Demeke et al., 1979). However, ergot poisoning is still a major
concern in domestic animals such as cattle, chicken, sheep, horses and pigs that
usually feed on contaminated grasses or grains (Bennett and Klich, 2003; Fribourg and
Waller 2005). It has been reported that cattle grazing on endophyte infected tall fescue
have lowered average daily weight gains, higher body temperatures, rougher coats,
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lowered prolactin production, and reduced conception rates (Fribourg and Waller,
2005). Ergot alkaloids have also been shown to affect rabbits, insects, and bacteria
(Eich and Pertz, 1999; Clay and Schardl, 2002; Panaccione and Schardl, 2003; Popay
and Bonos, 2005; Panaccione et al., 2006; Potter et al., 2008).
Ergot alkaloids have high biological activity and a broad spectrum of
pharmacological effects, hence they are of considerable importance to medicine. In
general, the pharmacological effects of all the ergot alkaloids appear to result from their
actions as partial agonists or antagonists at different adrenaline, dopamine, and
serotonin receptors, which further affect nervous, circulatory, reproductive, and immune
systems (Goetz and Diederich, 1992; Pertz and Eich, 1999; Ganetsky and Brush,
2005). Their roles as agonists or antagonists vary depending on which receptors they
bind (Stadler and Groger,1984). Ergot alkaloids in controlled doses can have a
therapeutic effect, and have been used in medicine as anti-migraine agents
(ergotamine), in treatment of Parkinson’s disease (bromocriptine), in treating postpartum hemorrhages and mastopathy, and to induce uterine contractions in childbirth
(ergonovine) (Kimball et al., 1989; Goetz and Diederich, 1992; Wadworth and Chrisp,
1992; van Dongen and de Groot, 1995; Barceloux, 2008). They also have a sedative
effect on the central nervous system. However, because of their lack of specificity for
individual monoamine receptors, they have a propensity for undesirable side effects
(Kozlovsky, 1999; Panaccione and Schardl, 2003).
Ergot alkaloids may also be synthesized in vitro. During the 1940’s, a Swiss
chemist named Albert Hofmann created the semi-synthetic ergot alkaloid lysergic acid
diethylamide (LSD), which became a well known recreational drug (Hofmann, 1980). He
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discovered the hallucinogenic properties of the drug after accidentally ingesting it. LSD
was used by psychiatrists and the Central Intelligence Agency (CIA) (Bennett and Klich,
2003). Use of LSD has been known to cause a condition known as serotonin syndrome,
which is a condition that shares similar clinical features with convulsive ergotism (Eadie,
2003; Ganetsky and Brush, 2005).

Ergot alkaloid producing fungi
The distribution of fungi producing ergot alkaloids appears to be non-coherent
paraphyletic. Several fungi representing the two distantly related orders within the
phylum Ascomycota, Eurotiales and Hypocreales, produce ergot alkaloids (Panaccione,
2005). Within the Hypocreales, ergot alkaloids have been most extensively studied in
the clavicipitaceous genus Claviceps and several fungi in the genera Epichloe and
Neotyphodium, which live as endophytic symbionts in grasses (Panaccione and
Schardl, 2003; Schardl et al., 2006). Claviceps spp. parasitize flowers of rye and related
cereal and forage plants and produce fungal overwintering bodies, the ergot sclerotia
that replace the host’s seeds. Consumption of grain or seeds contaminated with the
sclerotia can cause ergotism in humans and other mammals. Neotyphodium spp. and
their teleomorphs, Epichloë spp., are endophytes of cool-season grasses, such as tall
fescue and perennial ryegrass (Schardl et al., 2006). Endophytic association of the
plants can be either mutualistic or antagonistic (Clay and Schardl, 2002). Mutualistic
association can be seen in the case of Neotyphodium spp. which live in the host plant
asymptomatically, actively growing in the intercellular spaces and colonizing the plants
more extensively at the base of the pseudostem. During flowering, the endophyte
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colonizes the floral meristem wherein hyphae extensively colonize the seeds beneath
the seed coat. Thus the next generation seedlings become pre-inoculated with the
endophyte. The asexual fungi are transmitted only vertically via the infected seeds
(Craven et al., 2001; Clay and Schardl, 2002; Malinowski and Belesky, 2006). These
fungi have significant effects on their host plants such as increased tolerance to various
biotic and abiotic factors, including increased resistance to herbivores. Endophyte
infection has also been associated with increases in tiller number, seed production, and
root growth (Bush et al., 1997; Schardl and Phillips, 1997; Clay and Schardl, 2002;
Panaccione, 2005; Malinowski and Belesky, 2006).
In pathogenic associations, the endophyte grows asymptomatically inside the
host plant until the plant reaches the boot stage, after which the fungus reproduces
sexually by producing a fungal sexual structure, called a stroma that inhibits the
development of the grass inflorescence (Clay and Schardl, 2002). The most pathogenic
of these fungi are transmitted only horizontally. Some of the endophytic fungi such as E.
festucae can be transmitted both vertically and horizontally; they affect only some
inflorescences by forming stromata, whereas other inflorescences on the same plant
produce infected seeds (Schardl and Leuchtmann, 2005; Olejniczak and Lembicz,
2007).
Endophytes have also been associated with livestock toxicosis, which is
attributed, at least in part, to the ergot alkaloids that they produce (Hill et al., 1994;
Filipov et al., 1998; Gadberry et al., 2003). In the U.S.A., cattle and horses that grazed
on tall fescue inhabited by the endophyte N. coenophialum suffer from fescue toxicosis,
symptoms of which include low fertility, poor weight gain, poor milk production, low
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immunity, and dry gangrene of the limbs and tail (Lyons et al., 1986; Porter and
Thompson, 1992; Schardl and Phillips, 1997; Gadberry et al., 2003). Livestock toxicosis
can also be caused by several Claviceps species, endophytic fungi such as Epichloë
(anamorph Neotyphodium) spp. that complete their life cycles in association with coolseason grasses symbionts (Schardl, 1996; Schardl et al., 2009).
Several species of fungi belonging to the order Eurotiales, such as Aspergillus
fumigatus (Spilsbury and Wilkinson, 1961) and Penicillium commune (Kozlovsky, 1999),
which are common imperfect fungi, also produce ergot alkaloids. A. fumigatus is an
opportunistic pathogen capable of growing at temperatures up to 55 ºC and surviving at
70 ºC. It colonizes domestic and public buildings causing aspergillosis, especially in
immune-deficient individuals. The fungus grows in moist areas, such as basements and
ventilation system ducts; it also is ubiquitous outdoors, with higher concentrations in
areas surrounding compost and waste removal facilities. The fungus reproduces
asexually by producing conidia, which become airborne and can be inhaled by humans
and animals. In some cases inhaled conidia can infect and cause disease, act as an
allergen, cause toxicoses, or cause inflammatory responses (Fischer and Dott, 2003).

Classes of ergot alkaloids
Ergot alkaloids are group of natural biologically active compounds that range from
simple tricyclic to more complex tetracyclic alkaloids. Ergot alkaloids are considered
secondary metabolites because under ideal laboratory conditions, they are not essential
for survival of the fungus, yet they have an effect on other organisms that are exposed
to the fungus producing these alkaloids. The type of alkaloid produced depends on the
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pathway enzymes present in the producing fungus and the efficiency of the particular
pathway (Panaccione, 2005; Schardl et al., 2006). Ergot alkaloids are tryptophan
derivatives that contain a basic tetracyclic ergoline ring structure, which is methylated at
position N-6 (Fig. 1). Based on the substitutions present at the C-8 position of the
ergoline ring, they may be broadly divided into three groups: clavines, ergopeptines,
and simple amides of lysergic acid (Fig 1) (Flieger et al., 1997; Keller, 1999). Some
clavines, which are usually considered as the simpler ergot alkaloids, are precursors of
lysergic acid; whereas both simple amides and ergopeptines, non-ribosomally
synthesized peptides, derivatives formed from lysergic acid and three hydrophobic Laminoacids (Panaccione et al., 2006b; Schardl et al., 2006).
Clavines have been isolated from many Claviceps spp. and other non-ergot
fungi. Clavines can be further differentiated based on the presence of double bond
between carbon 8 and 9 or 9 and 10, or by presence of open form of ring D of the
tetracyclic ergoline ring which can be found in chanoclavine and members within the
subclass 6,7-secoergolines (Flieger et al., 1997). In some fungi such as A. fumigatus
and Claviceps fusiformis, clavines are the ultimate end products of the ergot alkaloid
pathway; however, in other ergot alkaloid-producing fungi they are intermediates to
more complex ergot alkaloids or as products of shunts off the pathway. Based on
feeding experiments using endophyte infected grasses in rabbits it was discovered that
apart from causing toxicoses, clavines also affect food preference by reducing the
appeal of the infected grasses (Panaccione et al., 2006a).
Simple amides of lysergic acid include lysergic acid amide (ergine) (Fig. 1),
ergonovine, lysergic acid-2-hydroxyethylamide, and lysergyl alanine (Panaccione and
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Schardl, 2003; Panaccione et al., 2003). They are produced by various fungi such as C.
paspali (accumulates ergine and lysergic acid-2-hydroxyethylamide), C. purpurea
(accumulates ergonovine and lysergyl-alanine), Neotyphodium sp. Lp1 and N.
coenophialum (accumulate ergine and lysergyl-alanine). Based on knock-out analysis in
Neotyphodium sp. Lp1, it has been determined that these alkaloids can accumulate as
by-products of ergopeptine synthesis as seen in the case of ergine and lysergyl alanine
(Panaccione and Schardl, 2003) or they can accumulate as ultimate end products of the
ergot pathway as in ergonovine in C. purpurea (Ortel and Keller, 2009).
Ergopeptines, also known as cyclol ergot alkaloids are the most complex ergot
alkaloids. They were also the first to be isolated and studied. They are nonribosomallysynthesized peptides that have three L-amino acids attached to D-lysergic acid via
peptide bond, which is catalyzed by a lysergyl peptide synthetase complex (Riederer et
al., 1996). The LPS complex is made up of two separate polypetides, LPS2 that
activates D-lysergic acid by adenylation, and LPS1, which recognizes and activates the
amino acids and forms the ergopeptines. Based on the amino acids that occupy
positions I and II of the tripeptide chain attached to lysergic acid, there is variation in the
composition of the ergopeptines (Fig. 2). Usually position III of the tripeptide chain is
occupied by amino acid proline, with the only exception being ergobalansine, where
position III is occupied by alanine (Keller, 1999). Based on the amino acid in position I of
the peptide, ergopeptines can be divided into three subclasses: the ergotamine group,
ergotoxine group, and ergoxine group. Based on the amino acid residing in position II
there is lot of variation in individual ergot alkaloids within subclasses (Table 1). Possible
amino acids occupying this position are phenylalanine, leucine, isoleucine, valine, and
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alpha-amino butyric acid (Schardl et al., 2006). Ergovaline is a major alkaloid found
within Neotyphodium spp., whereas ergosine and ergotamine are examples of abundant
ergopeptines within Claviceps spp. (Lyons et al., 1986; Panaccione, 2005).
Ergopeptams, are also known as noncyclol lactam ergot alkaloids, due to the
lack of hydroxylation reaction at the amino acid adjacent to lysergic acid (position I);
hence a cyclol bridge is unable to form with the amino acid in position III. They differ
from ergopeptines in having a D- proline and a noncyclol lactam tripeptide chain (Flieger
et al., 1997; Keller, 1999). Ergopeptams are further classified into the subclasses,
ergotamams, ergoxams, ergotoxams, and ergoannams based on aminoacid in positions
I and II (Table 2).

Diversity in the production of ergot alkaloids among producing fungi
Based on ergot alkaloid profiles and gene cluster analysis it has been elucidated that
ergot alkaloid producing fungi belonging to Hypocreales and Eurotiales, two distant
ascomycete orders, share early steps of the ergot alkaloid pathway; alternate pathways
diverge after these common early steps resulting in the production of different sets of
ergot alkaloids in different ergot alkaloid producing fungi. Aspergillus fumigatus,
belonging to order Eurotiales, accumulates several simple clavine alkaloids with a
saturated D ring like festuclavine, fumigaclavine A, and fumigaclavine B in the process
of producing the ultimate pathway end product fumigaclavine C. It does not produce any
complex lysergyl alkaloids (Coyle and Panaccione, 2005). Whereas several Claviceps,
Epichloe and Neotyphodium species (family Clavicipitaceae) usually accumulate a more
complex combination of clavines, ergopeptines, and simple amides of lysergic acid
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(Panaccione et al., 2006b). Neotyphodium sp. Lp1, an endophyte of perennial ryegrass,
accumulates relatively high concentrations of clavines and the ergopeptine ergovaline
(Panaccione et al., 2003; Panaccione et al., 2006b), but this accumulation may vary in
different host tissues (Table 3). Different species of Claviceps accumulate different
alkaloids in their overwintering structures, sclerotia (“ergots”). Claviceps fusiformis
accumulates clavines up through elymoclavine, and it completely lacks ergopeptines
and simple amides (Lorenz et al., 2007). C. purpurea accumulates mostly simple
amides of lysergic acid and ergopeptines (Tudzynski et al., 2001), whereas C. africana,
an ergot fungus of sorghum has high levels of clavines and dihydroergot type of
ergopeptines (Panaccione and Schardl, 2003).

Ergot alkaloid pathway inefficiency
In addition to the above indicated diversity in the ergot alkaloid profiles among different
fungi, ergot alkaloid structure and function also differ within an individual ergot alkaloid
producer. The ergot alkaloid pathway is relatively long (Fig.3) and product of the
pathway is not one single toxin but a mixture of end product, one or more intermediates
which accumulate to high concentrations, and alternate products that are produced by
short shunt pathways off of the main pathway (Panaccione, 2005). These shunt
pathways may influence pathway flux or accumulation of intermediates through the
main pathway, while also accounting for the production of additional products which
contribute to the diversity of ergot alkaloid profile (Panaccione, 2005). Some of the most
important shunt pathways include the ones that lead to the production of 6,7–
secolysergine in some Neotyphodium spp. endophytes (Panaccione et al., 2003) and
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setoclavine in some of the endophytic fungi belonging to Clavicipitaceae (Panaccione
and Schardl, 2003; Schardl et al., 2006). So, the ergot alkaloid pathway is considered
inefficient because there is limited direct flow of intermediates into one final end product;
instead there may be very high levels of intermediates accumulating at certain points in
the pathway, and also, in certain producers, these intermediates are diverted into
alternate products. In the perennial ryegrass endophyte Neotyphodium lolii x Epichloë
typhina isolate Lp1, the pathway is considered to be highly inefficient because of high
accumulation of intermediate (chanoclavine) and spur products (6,7-secolysergine and
setoclavine) relative to the pathway end product (ergovaline) (Panaccione et al., 2003;
Panaccione et al., 2006b). This flow of intermediates may also vary in different tissues
(Table 3). This pathway is also evident in A. fumigatus were there is difference in the
ergot alkaloid profile of mature conidia compared to the whole conidiating cultures
(Table 4). Based on studies with model animals and knockout endophytes, it has been
demonstrated that the pathway inefficiency, which results in accumulation of
intermediates and alternate products in addition to the end product, provides an
advantage to the producing fungus and its plant host (Panaccione et al., 2006a; Potter
et al., 2008). These studies have shown that intermediates and end products have
different biological activities, intermediates act as feeding deterrents and the pathway
end products have effective anti-insect activity (Panaccione et al., 2006a; Potter et al.,
2008). The pathway inefficiency that is accounted for in these fungi could be a result of
variation in the expression of different ergot alkaloid pathway genes. Different cell types
(in case of A. fumigatus) or hyphal compartments in different contexts (in case of
endophytes) could possibly express different subsets of ergot alkaloid pathway genes or
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all cell types could express all pathway genes but their expression is modulated in such
a way that it leads to accumulation of different ergot alkaloids. These questions can be
answered based on results from the GFP-based assays in A. fumigatus and real-time
PCR analysis in Neotyphodium sp. Lp1.

Objectives and potential impact of current study
The focus of this study is to understand the biochemistry of ergot alkaloid pathway
inefficiency in two different fungal species which differ markedly in development and life
history. Aspergillus fumigatus, a saprophytic and opportunistic human pathogen
provides us with the advantage of studying the pathway inefficiency in the different cell
types of the fungus. The other fungal species Neotyphodium lolii x Epichloë typhina
isolate Lp1, an obligate symbiont of perennial ryegrass enables us to study and
manipulate the pathway inefficiency in different tissues of the host plant.
The objectives of this study were to:
1. Investigate potential spatial basis for ergot alkaloid pathway inefficiency in A.
fumigatus by application of GFP-based assays.
2. Experimentally quantify the tissue specific variation of ergot alkaloid accumulation
due to pathway inefficiency in endophyte infected grasses.
3. Manipulate the ergot pathway inefficiency by genetically modifying the ergot alkaloid
gene expression in perennial ryegrass endophyte Neotyphodium sp. Lp1 through
overexpression and RNAi approaches.
Endophyte associated livestock toxicoses cause significant problems in
agriculture that might be ameliorated by using genetically modified endophytes
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produced by strategies developed in this research. Analysis of the pathway inefficiency
will aid in identifying the possible basis by which ergot alkaloid profiles are altered in
different fungi, this information can be further utilized in regulating the ergot pathway for
more beneficial purposes. Characterization of the ergot alkaloid pathway inefficiency
and the ability to control the spectrum of alkaloids produced may lead to advances in
these fields by providing a potential means of eliminating the undesired effects.
Knockdown and overexpression study analysis from this research can be extended to
other endophytic fungi were gene knockout studies are difficult to perform.
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FIGURE LEGENDS
Figure 1: Representatives of the three classes of ergot alkaloids. Ergot alkaloids
contain a basic ergoline ring structure indicated by the letters A-D within the alkaloid
ergine. Based on substitutions on C-8 (blue) and location of the double bond (red), ergot
alkaloids are divided into three groups: clavines which include festuclavine, simple
amides of lysergic acid represented by ergine and ergotamine which represents
ergopeptines.

Figure 2: Ergopeptines with varying amino acid substitutions. Ergopeptines are
nonribosomally-synthesized peptides that have three L-amino acids attached to Dlysergic acid. They can be differentiated based on specific amino acids that occupy
position R1 and R2. Usually, proline occupies the position R3. The table shows the
amino acids involved in the synthesis of six common ergopeptines.

Figure 3: Overview of hypothesized ergot alkaloid pathways of A. fumigatus
(indicated in red) and clavicipitaceous fungi (indicated in blue). DMAPP =
dimethylallylpyrophosphate; PPO = pyrophosphate; Trp = tryptophan; DMAT =
dimethylallyltryptophan. A. fumigatus and the clavicipitaceous fungi share early steps of
the ergot alkaloid pathway up until chanoclavine after which A. fumigatus produces
alkaloids indicated in red and clavicipitaceous fungi produce alkaloids indicated in blue.
The pathways involved in 6,7-secolysergine and setoclavine synthesis are the shunt
pathways that branch off the main pathway.
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Table 1. Representation of different subclasses of ergopeptine alkaloids
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Table 2. Representation of different subclasses of ergopeptam alkaloids
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Table 3. Percent of measured ergot alkaloids (molar basis) distributed among different
intermediates and products in perennial ryegrass tissues infected with endophyte Lp11
Ergot alkaloid

Leaf blades2

Pseudostems

Seeds

Chanoclavine

45

25

2

6,7-secolysergine

25

19

8

Setoclavine

4

7

0

Lysergic acid

0

0

12

Ergine

6

5

26

Lysergyl-alanine

1

0

5

Ergovaline

18

45

48

1

Preliminary data collected by D.G.Panaccione from multiple perennial ryegrass plants,
cv.Rosalin, infected with Neotyphodium sp.Lp1. However, samples were not necessarily
from the same individuals grown under identical conditions.
2

Values summed with columns vary from 100% due to rounding of multiple individual
values.
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Table 4. Percent of measured ergot alkaloids (molar basis) distributed among different
intermediates and products in cell types of cultured Aspergillus fumigatus1
Abscised conidial only2

Conidiating cultures3

Festuclavine

8

65

Fumigaclavine B

1

1

Fumigaclavine A

4

6

Fumigaclavine C

87

28

Ergot alkaloid

1

Unpublished data collected by C.M.Coyle and D.G.Panaccione

2

Agar based cultures of A.fumigatus that are grown inverted will abscise ( or shed)
mature conidia, which then accumulate on the lid of the culture plate, and can be
harvested separately from the remainder of the culture.
3

	
  

Composite of hyphae, condiophore vesicles, conidiophore phialides, and conidia.
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FIGURE 2.
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FIGURE 3.
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CHAPTER-2
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Spatial expression patterns of ergot alkaloid genes
during conidiophore development in Aspergillus
fumigatus

	
  

31	
  

ABSTRACT
Production of ergot alkaloids in the opportunistic fungal pathogen Aspergillus fumigatus
is restricted to conidiating cultures, which typically accumulate several pathway
intermediates at concentrations comparable to that of the pathway end product. I
investigated the contribution of different cell types that constitute the multicellular
conidiophore of A. fumigatus to the production of intermediates versus end product.
Conidiating cultures (containing hyphae, vesicle of conidiophore, phialides of
conidiophore, and conidia) accumulated more of the pathway intermediate festuclavine
and less of the pathway end product fumigaclavine C than did isolated mature conidia.
These data indicated differences in distribution or activity of ergot pathway enzymes.
Such differences also were indicated by studies with conidiophore mutants. A medA
mutant, which proliferates phialides, accumulated more pathway intermediates than did
the wild type or a complemented medA mutant. A stuA mutant, lacking recognizable
conidiophores, produced no detectable ergot alkaloids. Distribution of several ergot
alkaloid pathway enzymes among different conidiophore cell types was investigated by
labeling enzymes with autofluorescent proteins. Fluorescence associated with
expression of each tested gene indicated a similar pattern of spatial expression.
Fluorescence was not observed in young hyphae but was detected at the apices of
hyphae as they swelled to form the vesicle of the conidiophore. More fluorescence was
observed in mature vesicles, phialides, and conidia. No qualitative differences were
observed in cell type-specific expression of different pathway genes, indicating that
observed differences in accumulation of intermediates versus end product must be due
to quantitative differences in expression or differences in activity of pathway enzymes.
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INTRODUCTION
Ergot alkaloids are a complex family of tri- or tetracyclic mycotoxins that are derived
from prenylated tryptophan and have diverse structures and biological activities
(Schardl et al., 2006; Lorenz et al., 2009; Panaccione, 2010). Because of their ability to
act as partial agonists or antagonists at different adrenaline, dopamine, and serotonin
receptors they affect nervous, circulatory, reproductive, and immune systems.
Symptoms include reduced fertility, changes in blood pressure, lowered immune
response, hallucinations, disturbances in sleep-wake cycles and gangrene of the limbs.
Several fungi, representing two distantly related orders (Eurotiales and
Hypocreales) within the phylum Ascomycota produce ergot alkaloids (Schardl et al.,
2006; Panaccione, 2010). The ergot alkaloids of A. fumigatus, a common saprophyte
and opportunistic pathogen in the order Eurotiales, belong to the simpler class of
clavine alkaloids and include chanoclavine, festuclavine, fumigaclavine B, fumigaclavine
A, and fumigaclavine C (Fig. 1) (Cole et al., 1977; Panaccione and Coyle, 2005). The
synthesis of these alkaloids is controlled by specific genes in the ergot alkaloid pathway.
Those that will be analyzed in the current study include the following: dmaW which
controls the first determinant step of the ergot alkaloid pathway (Coyle and Panaccione,
2005; Unsöld and Li, 2005); easC and easE which are required for the formation of
chanoclavine (Lorenz et al., 2010; Goetz et al., 2011); easA which acts after
chanoclavine and contributes to the formation of festuclavine (Cheng et al., 2010; Coyle
et al., 2010); and, the last step of the pathway, which results in the formation of the end
product fumigaclavine C, is controlled by easL (Unsöld and Li, 2005).
Aspergillus fumigatus accumulates high concentrations of ergot alkaloids in or on
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conidia (Panaccione and Coyle, 2005). The ergot alkaloid pathway of A. fumigatus is
relatively long and several pathway intermediates accumulate to levels approaching or
exceeding that of the pathway end product, fumigaclavine C (Panaccione, 2005;
Panaccione and Coyle, 2005). Thus the ergot pathway is considered inefficient because
there is no rapid flow of intermediates into one final end product. A sporulating culture of
A. fumigatus develops four morphologically distinguishable cell types: long tubular
vegetative hyphae that grow in a polar fashion by apical extension; an aerial
conidiophore stalk that develops from the hyphae and terminates with a bulbous vesicle;
the phialide of conidiophore, which repeatedly produces conidia; and, the conidium
(Timberlake, 1991). The restriction of ergot alkaloids to conidiating cultures has been
established (Coyle et al., 2007), but the location of ergot alkaloid biosynthesis within
those cultures is unknown. Moreover, the documented inefficiency in converting ergot
alkaloid pathway intermediates may conceivably have a basis in differential distribution
of pathway enzymes among conidiophore cell types. The objectives for this current
study were to investigate potential differences in conidiophore cell-type specific
production of ergot alkaloids by separating cell types (where possible), to study ergot
alkaloid accumulation in conidiophore development mutants, and to determine the
expression of ergot alkaloid pathway enzymes in specific cell types by tagging them
with autofluorescent proteins.

MATERIALS AND METHODS
Fungi and culture conditions
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Aspergillus fumigatus strain Af293 was used as the wild-type strain. Two different
mutant strains derived from A. fumigatus Af293, ΔmedA (Gravelat et al., 2010) and

ΔstuA (Sheppard et al., 2005), also were studied. All A. fumigatus strains were cultured
on potato dextrose agar [PDA; 20 g/L dehydrated potatoes (Idaho Spuds; Pillsbury,
Minneapolis, MN), 20 g/L glucose, 15 g/L agar (Bacto agar; Difco, Detroit, MI)] at 37°C.
For protoplast preparation, the fungi were cultured overnight in 15 mL of malt extract
medium (50 g/L malt extract, 50 g/L lactose, 5 g/L asparagine, and 0.4 g/L K2HPO4) in a
deep Petri dish (depth, 20 mm; diameter, 100 mm; Fisher Scientific, Pittsburgh, PA) on
an orbital shaker (150 rpm) at 37°C. For fluorescent microscopy analysis, conidia from
GFP-expressing A. fumigatus strains were inoculated on microscopic slides covered
with glucose minimal medium (Shimizu and Keller, 2001) and incubated at 37°C.
Analysis of ergot alkaloids
Ergot alkaloids were extracted from ten sporulating culture plates each of the wild type
and mutant A. fumigatus strains that were grown at 37°C for five days. Agar plugs
containing 50.3 mm2 of colony surface area (cut with the broader end of a disposable tip
for a P1000 Pipetman) of the A. fumigatus cultures were crushed and extracted in 0.5
ml of 80% HPLC grade methanol as described by Coyle et al. (2007). Ergot alkaloids
were quantified from 20 µL of the supernatant by high-pressure liquid chromatography
(HPLC) over a C18 column [Prodigy 5 µm ODS3 (150 mm by 4.6 mm); Phenomenex,
Torrance, CA] with acetonitrile-ammonium acetate gradients and detected by
fluorescence (excitation and emission wavelengths of 272 nm and 372 nm, respectively)
(Panaccione et al., 2003; Panaccione and Coyle, 2005). For spore versus whole culture
ergot alkaloid analysis, the culture plates were first inverted and agitated to collect most
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of the conidia on the lid. Conidia were then suspended in methanol to extract alkaloids.
After removing most of the conidia an agar plug from the same culture plate was
suspended in methanol to analyze ergot alkaloids of the whole culture. The spore only
and whole culture suspensions were aliquoted for ergot alkaloid analysis and
enumeration of conidia. Spore counts were performed on spore only extracts and whole
culture extracts and alkaloids were expressed on a per spore basis. Peaks of alkaloids
chanoclavine, festuclavine, fumigaclavine A, fumigaclavine B, and fumigaclavine C were
detected based on methods employed in previous studies (Coyle and Panaccione,
2005; Coyle et al., 2010). Quantification of ergot alkaloids were based on comparison of
peak areas to those of the external standard agroclavine as described previously
(Panaccione and Coyle, 2005). Data from spore-only versus entire culture extracts were
analyzed by application of the Wilcoxon / Kruskal-Wallis (rank sums) test and those
from medA mutant strain were analyzed by ANOVA and, when appropriate, the TukeyKramer test. All analyses were performed with the JMP software package (SAS, Cary,
NC).
Generation of fluorescent protein tagged ergot alkaloid genes and transformation
The intact ergot alkaloid genes dmaW, easE, easC, easA and easL which catalyze
steps in the ergot pathway were amplified with their native promoters from wild-type
strain Af293 with the primers listed in Table 1. All PCR reactions were performed on
Bio-Rad C1000™ Thermal cycler and included 5X PCR buffer (Promega, Madison, WI),
1.6 mM MgCl2, 200 µM dNTP, 1 µM each primer, 0.2 µg DNA and 1 U GoTaq Flexi
DNA polymerase (Promega). Final volume for each reaction was 50 µL. The standard
PCR profile was as follows: 3 min at 94° C, 35 cycles of 30s at 94° C, 30s at annealing
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temperature, and 3 min at 72° C, followed by a final extension of 5 min at 72° C. The
annealing temperature varied depending on the target (dmaW, 61.1; easE, 57.0; easC,
57.7; easA, 52.0; easL, 52.0). For dmaW, easE, and easA genes, the amplified
fragments lacking the stop codon, were cloned in frame with Cycle 3 GFP of the
pcDNA3.1/CT-GFP-TOPO expression vector from the CT-GFP Fusion TOPO® TA
Expression Kit (Invitrogen, Carlsbad, CA), according to manufacturer’s instructions. For
easL, which catalyzes the final step of the ergot pathway, the gene lacking stop codon
was amplified with gene specific primers and cloned as a BamHI–AgeI fragment into a
red fluorescent pDSRed2 vector from Clontech Laboratories, Inc. (Palo Alto, CA). The
recombinant vector, pXFP (X= dmaW, easE, easA and easL) allowed expression of
ergot alkaloid genes with Cycle 3 GFP and RFP respectively fused at its C-terminus.
For easC, a potential C-terminal peroxisomal signal (amino acid residues SRL) was
observed, so an N-terminal GFP fusion plasmid [pXFP (X= easC)] was constructed in
order to prevent any interference of the GFP with the signal. The orientation of the insert
and sequence of all the plasmids were confirmed by sequencing. Protoplasts were
prepared and transformed as described by Coyle et al. (2010). Cotransformation of the
protoplasts was performed with the linearized fluorescent protein fusion construct,
pXFP, and a hygromycin resistance plasmid, pMOcosX (Orbach, 1994), that had been
linearized at a unique XhoI site (Coyle et al., 2007). Colonies growing on the
transformation plates were screened for the presence of pXFP construct by PCR assay
with primers that were specifically designed to target fluorescent protein coding
sequence. In case of easC-GFP, a second transformant was made in which the GFP
construct was targeted to the ergot gene cluster. This was done to test whether the
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spatial pattern of expression was affected by the integration site of the GFP construct.
Transformants were screened for homologous recombination of the plasmid peasCFP
with the primer easCScrnF, which anneals to 5′ end of the easC gene and flanking the
targeted site of integration and easCScrnR which anneals specifically to vector
sequence (Table 1). Transformants yielding a fragment of 0.7 kb for homologous
recombination at easC were purified to nuclear homogeneity along with transformants
that had ectopic integration of easC by culturing them from individual, germinated
conidia. Single spore colonies were again screened by PCR for the presence of pXFP
fusion construct.
Microscopic techniques
Colonies of strains expressing GFP were visualized by a Nikon Eclipse TE2000-S
inverted microscope (Nikon, Tokyo, Japan) equipped with a 100 W mercury vapor lamp.
Green and red filter sets were used to detect the GFP and RFP proteins, respectively.
Pictures were taken with a Q Imaging Retiga 2000R camera equipped with Qcapture
2.90.1 software (Quantitative Imaging Corporation, Surrey, British Columbia, Canada)
and processed with Adobe Photoshop CS5 (Adobe Systems Inc., San Jose, CA).

RESULTS
Ergot alkaloid content of whole sporulating cultures compared to mature,
abscised conidia
Cultures of wild-type A. fumigatus contained morphologically distinct cell types:
vegetative hyphae, stalk with vesicle of conidiophore, phialides of conidiophore, and
conidia. Samples from the entire culture (and thus containing all the four cell types)
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contained an average of 3.3 fg of total ergot alkaloids per conidium, whereas samples
made up exclusively of mature abscised conidia contained an average of 1.2 fg of total
ergot alkaloids per conidium, indicating that cell types other than conidia contributed to
the ergot alkaloid yield of the whole cultures. The difference in accumulation of total
ergot alkaloids per spore between whole cultures (made up of different cell types) as
compared to isolated, mature conidia was statistically significant (P=0.002). The
proportion of festuclavine (the intermediate that accumulates to the highest
concentrations) relative to total ergot alkaloids extracted was significantly greater in
whole-culture extracts than in mature spore extracts (P=0.0002) (Fig. 2). The converse
was true for the three alkaloids downstream from festuclavine, fumigaclavine B
(P=0.0002), fumigaclavine A (P=0.0025), and fumigaclavine C (P=0.0002) (Fig. 2).
Ergot alkaloid profiles of wild type, and ΔstuA and ΔmedA mutants and their
complemented derivatives
The ΔstuA mutant strain of A. fumigatus, lacking vesicles and phialides (Sheppard et al.,
2005), contained no detectable ergot alkaloids, and the corresponding complemented
strain had a profile similar to that of the wild type (data not shown). In contrast,
conidiating colonies of the ΔmedA mutant strain, which has multiple layers of phialides
(Gravelat et al., 2010), accumulated higher amounts of total ergot alkaloids per
conidium than did the wild-type (P=0.03). However, levels of the end product of the
pathway (fumigaclavine C) were not significantly different in the ΔmedA mutant and
wild-type (P=0.33) (Fig. 3A). The medA mutant, in comparison to the wild type,
accumulated a significantly higher proportion of combined pathway intermediates
(chanoclavine, festuclavine, fumigaclavine B, and fumigaclavine A) compared to levels

	
  

39	
  

of pathway end product (fumigaclavine C) (P<0.0001) (Fig. 3B).
Spatial localization of ergot alkaloid pathway genes during conidiophore
development
Ergot pathway gene products were observed at different time points in order to capture
their localization patterns in all the asexual development stages of A. fumigatus.
Fluorescence was not detected during the vegetative growth of the fungus and was first
observed during conidiophore development. Similar spatial localization patterns were
observed for all the genes tested in the study. In young conidiophores, the fluorescence
was not randomly distributed but rather visualized as localized near the tip of the
developing conidiophore (Fig. 4 A, E, I, M, Q) and to the zone that later became the
phialide-bearing region of the conidiophore vesicle (Fig. 4 B, F, J, N, R). Extensive
fluorescence was observed in the mature phialides that developed from the vesicle (Fig.
4 C, G, K, O, S). Fluorescence was also observed in the conidia that developed from
the mature phialides (Fig. 4 D, H, L, P, T). In the case of easL-RFP expressing A.
fumigatus strain, greater fluorescence was observed in conidia relative to conidiophores
(Compare Fig. 4 T and S) when compared to the relative fluorescence of conidia versus
conidiophores of any of the other fluorescently labeled enzymes. The non-transformed
wild-type strain did not fluoresce under the same observation conditions (data not
shown). There was no difference in the expression patterns between the ectopic and
cluster integrated easC-GFP expressing A. fumigatus strains (data not shown).

DISCUSSION
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Results from this study have provided new information on the developmental regulation
of ergot alkaloid biosynthesis in A. fumigatus. Comparative alkaloid analysis of entire
sporulating culture extracts and a spore only extracts demonstrated that ergot alkaloids
are in fact produced in cell types that constitute a developing conidiophore in addition to
the conidia of A. fumigatus. This was further confirmed by analysis of different cell-type
mutants. The “medusa” mutant (ΔmedA), which has an abnormal phenotype with
excess phialides and fewer conidia than wild-type (Gravelat et al., 2010), showed higher
accumulation of pathway intermediates when compared to end products of the pathway.
The “stunted” mutant (ΔstuA) with no vesicle or phialides and very few conidia
(Sheppard et al., 2005) did not produce any detectable ergot alkaloids. Although this
mutant produces very few conidia, the number of conidia extracted from the samples
would have yielded ergot alkaloids at concentrations of at least 200-times the detection
threshold if they contained alkaloids typical of wild-type conidia. These results raised the
question of whether the pathway inefficiency that leads to differential accumulation of
ergot alkaloids is due to cell-type specific expression of ergot alkaloid genes.
Autofluorescent protein expression studies of different ergot alkaloid pathway
genes showed no detectable fluorescence in vegetative hyphae, supporting the
hypothesis that these alkaloids are produced only during sporulation as opposed to
during vegetative growth of the fungus (Coyle et al., 2007; Twumasi-Boateng et al.,
2009). Fluorescence was initially localized to the tips of hyphae that were differentiating
into conidiophores; it was observed to be more evenly distributed in subsequent cell
types. Spatial expression patterns were observed for all tested ergot alkaloid genes in
specific cell types of the multicellular conidiophore, but no clear qualitative cell-type
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specific differences in the expression of individual genes were detected. This suggests
that quantitative differences in the expression of these genes in each cell type could
account for the observed differential accumulation of intermediates versus end product
of the ergot alkaloids pathway. Greater fluorescence of the easL-RFP construct was
observed in conidia relative to conidiophores compared to the relative fluorescence of
conidia versus conidiophores of any of the other fluorescently labeled enzymes.
Whereas this difference is apparent from comparing the relevant panels in Fig. 4,
definitive conclusions cannot be made because quantifying the fluorescence from
different cell types is extremely difficult due to the close association of those cell types.
Elevated expression of the reverse prenyl transferase encoded by easL in conidia as
compared to conidiophores result in accumulation of end product fumigaclavine C to
higher concentration in conidia.
Recent evidence from knock-out studies and transcriptome analysis have
indicated that all ergot alkaloid genes of A. fumigatus are regulated by trans-acting
transcription factors such as brlA and stuA (Coyle et al., 2007; Twumasi-Boateng et al.,
2009). Moreover, it has been shown that genes that are targeted by similar transcription
factors are co-expressed (Marco et al., 2009). This may explain the overall similar
spatial patterns of expression observed in case of all tested ergot alkaloid genes.
Furthermore, in this study many of the GFP-fused ergot alkaloid gene constructs
integrated ectopically in the genome; since these ergot alkaloid genes are regulated by
trans-acting transcription factors, the effect of position in the genome should be minimal.
This hypothesis is supported by the observations from the ectopic and cluster integrated
easC-GFP expressing A. fumigatus strains.
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In conclusion, the ergot alkaloid pathway of A. fumigatus functions
differently in different cell types associated with conidiation, resulting in higher
concentrations of intermediates in extracts containing all cell types of conidiating
cultures and higher concentration of end product in mature, abscised conidia. Several
ergot alkaloid cluster genes are expressed in all cell types that constitute the mature
conidiophore of A. fumigatus. Thus, pathway inefficiency which leads to higher
accumulation of intermediates in certain cell types is not due to qualitative cell typespecific expression of ergot alkaloid genes. However, the possibility that quantitative
differences in expression of easL result in accumulation of the end product
fumigaclavine C in conidia more than in conidiophores was supported by observation.
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FIGURE LEGENDS
Figure 1. Ergot alkaloid biosynthetic pathway of A. fumigatus. Multiple arrows indicate
omitted intermediates. Steps catalyzed by genes included in the current study are
indicated.

Figure 2. Proportion of individual ergot alkaloids relative to the total ergot alkaloids
extracted in a sporulating culture containing all cell-types (black bars) vs samples of
abscised conidia (grey bars). A significant difference (P<0.05) was found when
comparing each ergot alkaloid between sample types with the nonparametric Wilcoxon /
Kruskal-Wallis rank sum test. Error bars represent standard error. The insert represents
a magnified view (note scale on Y axis) of proportions of fumigaclavine A and B.

Figure 3. Ergot alkaloid content of ΔmedA mutant versus wild-type A. fumigatus. (A)
Total ergot alkaloids (black bars) and pathway end product fumigaclavine C (grey bars)
among wild-type, ΔmedA mutant, and ΔmedA complemented strain. (B) Ratio of ergot
alkaloid pathway intermediates (sum of chanoclavine, festuclavine, fumigaclavine A,
and fumigaclavine B) to end product (fumigaclavine C) in wild type, ΔmedA mutant, and
ΔmedA complemented strain. Standard error is shown by the error bars. Strains labeled
with the same letter do not differ significantly according to the Tukey-Kramer honestly
significant difference test (P<0.05).

Figure 4. Spatial localization pattern of different ergot alkaloid genes of A. fumigatus
during conidiophore development. Representative DIC and fluorescent images are
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provided for strains expressing fluorescent protein tagged dmaW, easC, easE, easA,
and easL ergot alkaloid pathway genes (A-T). Fluorescence localized to the tip of
conidiophore stalk (fluorescence panel associated with A, E, I, M, and Q), the upper part
of the vesicle that eventually becomes the phialide bearing region (fluorescence panel
associated with B, F, J, N, and R), phialides of the conidiophore (fluorescence panel
associated with C, G, K, O, and S), and conidia formed on mature conidiophores
(fluorescence panel associated with D, H, L, P, and T). All images were captured under
similar exposure time (1.98 s). Bar, 10µm.
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TABLE 1. Primers used in this study. F, forward primer; R, reverse primer.
Target
gene
dmaW

Size
(bp)
2300

5' UTR 3' UTR Primer
(bp)
(bp)
name
783
dmaW-F
dmaW-R

easC

3358

1072

644

easC-F
easC-R

easE

2619

650

-

easE-F
easE-R

easA

1915

787

-

easA-F
easA-R

easL

2089

729

-

easL-F
easL-R

GFP

719

gfp-F
gfp-R

easC

746

easCScrnF
easCScrnR

	
  

Sequence 5'- 3'
GAGTGGTGTTGAGAGCTG
CCCAC
GGTGGAGACCGGAATAAT
ATACCC
TGAACAGCTCGGGACTTAC
TTC
CAGCAGATGGAGCAAGTG
ACTT
GAGAGTCATCTTGGATAAG
GGC
GGCGGTATACCCGCTGGG
CAATGC
GTGCGGAGTGCCTACTCTA
TAG
GGACGGGGAAATTATGCA
ATGC
GACGGATCCTTATTAGAGA
AGATGCTCTAAGTGG
GCAACCGGTGGAAAGACG
GGTCGTGGCCCGCTG
GCAGAATTCATGGCTAGCA
AAGGAGAAGAAC
GCAGAATTCTTTGTAGAGC
TCATCCATGCC
GGGCTATGGTGAAGGATG
CTTCC
CGGTCGCGGGATCGCGGG
CGAGG
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FIGURE 1.
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FIGURE 2.
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FIGURE 3.

Total ergot alkaloids

A

Fumigaclavine C only

Ergot alkaloids
fmol/conidium

0.06

B

0.04

0.02

AB
a

a

A

a

0
wt

medA

medA comp

Ratio of intermediates to
end product

B
3
B

2

1

A
A

0
wt

	
  

medA

medA comp

52	
  

FIGURE 4.
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CHAPTER-3
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Investigation and genetic modification of ergot
alkaloid pathway efficiency of Neotyphodium lolii ×
Epichloë typhina isolate Lp1 (Neotyphodium sp. Lp1)
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ABSTRACT
The ergot alkaloid pathway of Neotyphodium lolii × Epichloë typhina isolate Lp1
(Neotyphodium sp. Lp1), an endophytic symbiont of perennial ryegrass, is considered
highly inefficient because of high accumulation of several pathway intermediates and
shunt products in addition to the pathway end product. I investigated if pathway
efficiency varied by tissue. My results demonstrated that different tissues of the host
plant accumulated different profiles of ergot alkaloids as well as different total
concentrations, indicating a potential tissue specific variation of expression of ergot
pathway genes. Alteration of the expression of the ergot alkaloid pathway gene easA by
RNA interference (RNAi) and over-expression techniques resulted in genetic
manipulation of the flux of metabolites down the pathway. When compared to wild type,
knock-down of easA resulted in higher accumulation of pathway intermediate
chanoclavine and shunt product 6,7-secolysergine in comparison to pathway end
product ergovaline. In contrast, over-expression of easA resulted in higher pathway
ergovaline accumulation and no significant difference in the accumulation of
intermediates and shunt products of the pathway. Collectively, my results indicate that
ergot pathway genes are regulated differently in different tissues resulting in different
profiles of ergot alkaloids. Also in Neotyphodium sp. Lp1, the concentration of easA
mRNA has a significant role in controlling the efficiency in the flow of intermediates
down the ergot alkaloid pathway.
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INTRODUCTION
Ergot alkaloids are mycotoxins that are derived from prenylated tryptophan and have
varied biological activities (Schardl et al., 2006). They have been implicated in human
toxicoses since medieval times. Toxic effects such as lowered immune responses,
changes in blood pressure, hallucinations, gangrene of the limbs, reduced reproductive
capability, and disturbances in sleep-wake cycle are caused by the ability of these
alkaloids to act as partial agonists or antagonists at various serotonin, dopamine, and αadrenaline receptors (Goetz and Diederich, 1992; Pertz and Eich, 1999; Ganetsky and
Brush, 2005). Several fungi, representing two distantly related orders, Eurotiales and
Hypocreales, within the phylum Ascomycota produce ergot alkaloids (Schardl et al.,
2006; Panaccione, 2010). Within the Hypocreales, they have been most extensively
studied in the clavicipitaceous genera Claviceps and several fungi in the genera
Epichloë and Neotyphodium, which live as endophytic symbionts in grasses (Schardl et
al., 2006; Panaccione, 2010).
Neotyphodium spp. form symbiotic associations with cool-season grasses, such
as tall fescue and perennial ryegrass, in which they grow in the intercellular spaces and
colonize extensively at the base of the pseudostem. These endophytes are completely
reliant on their host plant for existence and are transmitted only vertically via infected
seeds (Clay and Schardl, 2002; Malinowski and Belesky, 2006). Neotyphodium spp.
impart many significant traits to their host plants including tolerance to various biotic and
abiotic stress factors and increased resistance to herbivores. They have also been
associated with increases in tiller number, seed production, and root growth (Bush et
al., 1997; Schardl and Phillips, 1997; Clay and Schardl, 2002; Panaccione, 2005;
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Malinowski and Belesky, 2006). In spite of their positive impact on the grasses,
Neotyphodium spp. endophytes often are considered undesirable because of their
negative effects on livestock. They often cause livestock toxicosis which is at least in
part attributed to the ergot alkaloids that they produce (Hill et al., 1994; Filipov et al.,
1998; Gadberry et al., 2003).
The ergot alkaloid pathway (Fig. 1) is relatively long and results in not just one
final pathway end product but rather a mixture of end product, one or more
intermediates, which accumulate to high concentrations, and alternate products that are
produced by short shunt pathways off of the main pathway (Panaccione, 2005). These
shunt pathways may influence pathway flux or accumulation of intermediates through
the main pathway along with the production of additional products which results in the
varied ergot alkaloid profile (Panaccione, 2005). So, the ergot alkaloid pathway is
considered inefficient because there is reduced direct flow of intermediates into the final
end product. Neotyphodium lolii × Epichloë typhina isolate Lp1 (Schardl et al., 1994), an
endophyte of perennial ryegrass, produces a wide range of ergot alkaloids including
clavines, ergopeptines, and simple amides of lysergic acid. In particular, Neotyphodium
sp. Lp1, accumulates relatively high concentrations of the clavines chanoclavine and
6,7-secolysergine and the ergopeptine ergovaline (Panaccione et al., 2003; Panaccione
et al., 2006). Apart from these, it also accumulates ergine and lysergyl alanine as byproducts of ergopeptine synthesis. Based on studies with animal models and knockout
endophytes, it has been demonstrated that the pathway inefficiency provides an
advantage to the producing fungus and its plant host because both clavines and
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lysergic acid derivatives provide benefits to the host plant (Panaccione et al., 2006;
Potter et al., 2008).
The objectives of this study were to investigate the potential reasons behind
pathway inefficiency, determine if pathway efficiency varies between different tissues,
and to manipulate the flow of metabolites through the ergot alkaloid pathway by altering
the expression of easA employing RNA interference (RNAi) and overexpression
strategies.

MATERIALS AND METHODS
Fungi and growth conditions.
Neotyphodium sp. Lp1 was cultured on potato dextrose agar (PDA; 20 g/L dehydrated
potatoes (Idaho Spuds; Pillsbury, Minneapolis, MN), 20 g/L glucose, 15 g/L agar [Bacto
agar; Difco, Detroit, MI]) at 20°C. For protoplast preparation, the fungus was cultured for
seven days in 50 mL of potato dextrose broth (PDB) in a 250 ml flask on an orbital
shaker (200 rpm) at 20°C.
Construction of easA RNAi and overexpression vectors.
A standard PCR strategy was employed to generate RNAi and overexpression
constructs. All PCR reactions included: 5X PCR buffer (Promega, Madison, Wl) with no
magnesium, 1.6 mM MgCl2, 200 µM dNTP, 1 µM each primer, 0.2 µg DNA (from
Neotyphodium sp. Lp1) and 1 U GoTaq Flexi DNA polymerase (Promega) in a 50 µL
final volume. The standard PCR profile for all reactions was as follows: 3 min at 94°C,
35 cycles of 30 s at 94°C, 30 s at 56°C and 3 min at 72°C, followed by a final extension
of 5 min at 72°C. All primers used to generate these constructs are listed in Table 1.
Generation of easA RNAi construct:
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Using primers RNAi-1F and RNAi-2R, a DNA fragment was amplified containing 450 bp
easA coding sequence, followed by 11 bp of an intron sequence from easG gene that
was artificially engineered into the reverse primer because easA lacks any natural
introns. In a second PCR with primers RNAi-3F and RNAi-4R, a DNA fragment was
generated containing 36 bp of the remaining intron sequence of easG gene that was
incorporated into the reverse primer followed by 450 bp of the easA coding sequence in
reverse-complement orientation. After PCR, both fragments were pooled and digested
with BsrGI (BsrGI recognition sites were built into primers RNAi-2 and RNAi-3) and
ligated to yield a 947 bp fragment. The fragment was then digested with XhoI and NotI
(recognition sites for which were built into the 5'-ends of primers RNAi-1 and RNAi-4,
respectively), ligated into XhoI and NotI digested pCB1004, and electroporated into
Escherichia coli cells. The resulting transformants were selected on chloramphenicol.
The plasmid vector, pEASAi (Fig. 2A) was isolated, and integrity of the easA-RNAi
construct was checked by sequencing into the insert from flanking vector regions.
Sequencing of the coding regions of easA was greatly inhibited by secondary structure
formation, so digestion with different restriction enzymes and analysis of the restricted
fragments was performed to confirm that the desired construct had been obtained.
Transcription of the easA-RNAi fragment was driven by a strong toxA promoter which
was amplified from Pyrenophora tritici-repentis DNA with primers toxA-F and toxA-R
and cloned as a KpnI-XhoI fragment into pCB1004, prior to cloning the easA-RNAi
segment into the plasmid. The trpC terminator was amplified from Aspergillus nidulans
trpC gene using primers trpC-F and trpC-R and inserted it at a unique SacI site in the
plasmid.
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Generation of easA overexpression construct:
In order to overexpress the easA gene, easA coding sequence was fused to the
promoter of gigA from Neotyphodium sp. Lp1 (Johnson et al., 2003), which is the most
highly expressed endophyte gene during symbiosis. Using primers easAO-1 and
easAO-2, the easA coding sequence was amplified as a 1551 bp DNA fragment
containing NotI and BsrGI sites at the 5’ and 3’ end respectively. The promoter of Nc25
was amplified as a 576-bp XhoI-BsrGI fragment with primers Nc25-F and Nc25-R. The
PCR products were then purified, pooled, digested with BsrGI, and ligated. The
resulting 2127 bp fragment was then digested with XhoI and NotI and cloned into XhoI
and NotI digested pCB1004 vector and electroporated into E. coli cells. The plasmid
vector, pEASAo (Fig. 2B) was isolated from transformants and integrity of the construct
was checked by sequencing.
Fungal transformation and plant infection.
Protoplasts were prepared and transformed based on methods described by
Panaccione et al. (2001). Transformants were selected for on a medium containing 200
µg mL–1 hygromycin B (Calbiochem, San Diego, CA). After 5 weeks, viable hygromycinresistant fungal colonies were transferred onto PDA to induce sporulation. The
transformants were then screened for integration of the desired plasmid construct by
PCR by primers hyg-F and hyg-R, which target the hygromycin resistance gene of the
plasmid. Positive transformants were purified to nuclear homogeneity by culturing them
from single spores. Perennial ryegrass cv. Rosalin were inoculated with single-spored
genetically modified endophytes according to methods described by Panaccione et al.
(2001).
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Analysis of ergot alkaloids.
Ergot alkaloids were extracted from 50 mg of dried powdered plant material as
described previously by Panaccione et al. (2006). Ergot alkaloids were quantified from
20 µL of the supernatant by high-pressure liquid chromatography (HPLC) over a C18
column (Prodigy 5-µm ODS3 [150 mm by 4.6 mm]; Phenomenex, Torrance, CA) with
acetonitrile-ammonium acetate gradients. Chanoclavine was detected by a fluorescent
detector set at excitation and emission wavelengths of 272 nm and 372 nm,
respectively. All other ergot alkaloids were detected by excitation at 310 nm and
emission at 410 nm (Panaccione et al., 2006). Quantification of ergot alkaloids was
based on comparison of peak areas to those of internal standard ergotamine-tartrate
(Sigma, St, Louis, MO) that was added to the plant material along with the extraction
buffer. Data was analyzed by ANOVA using the general linear models procedure of
SAS (Cary, NC).

RESULTS
Tissue specific accumulation of ergot alkaloids.
Ergot alkaloids were detected and quantified in different perennial ryegrass tissues
colonized with wild-type Neotyphodium sp. Lp1. Concentrations of total alkaloids that
include pathway intermediate chanoclavine, shunt products 6,7-secolysergine and
setoclavine, and end products ergine and ergovaline differed significantly in
pseudostem, center leaf blade, outer leaf blade, flag leaf, inflorescence, and dough
stage seeds (P = 0.0001) (Fig. 3). Dough stage seeds accumulated the highest
conentrations of total alkaloids followed by pseudostems. Total alkaloids were of similar
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concentrations in the outer leaf blade, center leaf blade and inflorescence but differed
significantly from dough stage, pseudostem, and flag leaf. Flag leaf tissue had very low
total alkaloid concentrations with only detectable 6,7-secolysergine and ergine alkaloids.
Concentrations of individual alkaloids varied significantly within and among tissues
representing different developmental stages of the plant (P < 0.05) (Fig. 4). Within
individual tissues, dough stage seeds and pseudostems accumulate high amounts of
pathway end product ergovaline when compared to all other alkaloids. Conversely,
inflorescence tissue accumulates higher chanoclavine levels and lower amounts of
other alkaloids. When concentrations of different alkaloids were compared among
tissues, the pathway intermediate chanoclavine accumulated in significantly higher
concentrations in pseudostems, inflorescence, and dough stage (P < 0.05) than in other
tissues. Shunt product 6,7-secolysergine was detected in higher concentrations in
dough stage seeds (P < 0.05), which also accumulated very high concentrations of
pathway end products. Setoclavine was rarely detected in any of the host tissues.
Transcript accumulation data were also looked at in terms of expression of
individual genes in all the different tissues used in the study. This work was performed
by Dr. Simona Florea in the laboratory of Dr. Christopher Schardl at the University of
Kentucky and is described in Appendix 1.
Ergot alkaloid analysis of the plants colonized by genetically modified endophyte
strains.
Alteration of mRNA levels of easA employing RNAi and overexpression strategies
changed the flow of metabolites through the ergot alkaloid pathway of Neotyphodium
sp. Lp1. When compared to the wild-type, plants colonized by two of the three different
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strains of easA RNAi fungi and easA overexpressing Neotyphodium sp. Lp1 differed
significantly in accumulation of ergot alkaloids (Fig. 5-8). Each strain represented an
independent, random integration event.

Alteration of ergot alkaloid profiles in pseudostem and outer leaf blades of plants
infected by easA RNAi strains:
Plants colonized by Neotyphodium sp. Lp1 strain in which easA has been knocked
down by RNAi showed significant differences in the accumulation of an ergot alkaloid
pathway intermediate, a by-product, and an end product. Pseudostems colonized by
easA-RNAi-1 fungus had significantly higher accumulation of chanoclavine (P =
0.0050), an early pathway intermediate, and 6,7-secolysergine, a pathway shunt
product (P = 0.0075), and lower accumulation of ergovaline (P = 0.013), the end product
of the pathway, than did pseudostems colonized with the wild type (Fig. 5A). Outer leaf
blades from the same plants also accumulated significantly high concentrations of 6,7secolysergine (P = 0.0148) and less ergovaline (P = 0.0008) (Fig. 6A), when compared
to the wild type. No detectable chanoclavine was found in the outer leaf blades. Similar
results were measured in pseudostems and leaf blades colonized by strain easA-RNAi2 strain (Fig. 5B and 6B). In contrast, accumulation of ergot alkaloids in plants infected
with strain easA-RNAi-3 did not differ significantly from that of wild type-infected plants
(Fig. 5C and 6C).
In collaboration with Drs. Florea and Schardl (University of Kentucky), transcript
accumulation of easA was also looked at in the same samples of pseudostem that were
used for alkaloid analysis (Appendix 1).
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Alteration of ergot alkaloid profiles in pseudostem and outer leaf blades of plants
infected by easA overexpression strains:
Pseudostems colonized by easA-overexpression-1 strain had significantly more
ergovaline, the pathway end product, (P = 0.014) and no significant difference in
accumulation of intermediate chanoclavine and by-product 6,7-secolysergine (Fig. 7A),
when compared to the wild type. Outer leaf blades from the same plants also
accumulated significantly more ergovaline than plants infected with the wild type (P =
0.018) (Fig. 8A). No difference in the levels of 6,7-secolysergine were detected in leaf
blades when compared to the wild type (Fig. 8A). Chanoclavine was not detected in the
outer leaf blades. Similar alkaloid concentrations and distribution was detected in
pseudostems and leaf blades colonized by the easA-overexpression-2 strain (Fig. 7B
and 8B). In contrast, easA-overexpression-3 strain did not show any significant
difference in the accumulation of ergot alkaloids when compared to wild type (Fig. 7C
and 8C).
In collaboration with Drs. Florea and Schardl (University of Kentucky), transcript
accumulation of easA was also looked at in the same samples of pseudostem that were
used for alkaloid analysis (Appendix 1).

DISCUSSION
Results from this study have provided new insights into how different ergot alkaloid
profiles can result from differing efficiency in turning over intermediates in the ergot
alkaloid pathway of Neotyphodium sp. Lp1 that is symbiotic with perennial ryegrass.
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Results from analysis of different tissues of perennial ryegrass infected with the wild
type showed that the ergot alkaloid pathway efficiency varies at tissue level. mRNA from
various ergot alkaloid pathway genes was present in all tissue type (Appendix 1) but
variation in levels of individual genes may account in part to the varied levels of
alkaloids detected in these tissues. Through RNAi and over-expression transformant
analysis, I have established that alteration of easA mRNA can change the efficiency of
the ergot alkaloid pathway in Neotyphodium sp. Lp1. When compared to wild type,
transformants with RNAi-mediated knock down of easA had higher accumulation of
pathway intermediate chanoclavine and shunt product 6,7-secolysergine and lower
accumulation of pathway end product ergovaline. Furthermore, over-expression of easA
resulted in a very high accumulation of pathway end product ergovaline compared to
the wild type, but there was no significant difference in the accumulation of intermediate
chanoclavine and shunt product 6,7-secolysergine alkaloid.
Results from analyses of ergot alkaloids in various tissues of perennial ryegrass
showed that ergot alkaloid profiles differed by tissue, with some tissues, like dough
stage of seeds, being more efficient in turning over intermediates and other stages, like
inflorescences, being highly inefficient. Analyses of mRNA from several ergot alkaloid
pathway genes indicate that ergot alkaloid pathway efficiency is influenced by the
accumulation of mRNA for different ergot alkaloid pathway enzymes (Appendix 1). All
the ergot pathway genes tested in the study were ubiquitously expressed in all the
tissues, but there was differential expression of these genes in different tissues which
may contribute to the difference in ergot alkaloid accumulation (Appendix 1). This is
exemplified by the high abundance of lpsA mRNA in pseudostems and center leaf blade
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and cloA in dough stage seeds which may contribute to the higher accumulation of
pathway end product in these tissues (Appendix 1).
In addition to variation in profiles, different tissues varied in accumulation of total
ergot alkaloids. Pseudostems and dough stage seeds had higher accumulations of
alkaloids, whereas flag leaf had very low levels of alkaloids which can be due to the low
fungal biomass in flag leaf and higher fungal biomass in pseudostem and dough stage
seeds (S. Florea and C.L. Schardl, pers.com). In addition to mRNA abundance, relative
fungal colonization of different tissues, substrate availability in different tissues, and
translocation of alkaloids from their site of synthesis also could affect the levels of
alkaloids in different tissues.
Neotyphodium sp. Lp1 is a systemic and seed-transmitted obligate symbiont of
perennial ryegrass that is completely reliant on the host plant for its existence. Since the
fungus is dispersed only via infected seeds (Schardl, 1996), it has to defend the host
resources, thereby enhancing its frequency of transmission into the next generation.
Therefore, an inefficient pathway that results in the varied profiles of alkaloids in
different tissues would be selected for if intermediates and end products provided
different benefits to the host plant. Recent evidence from studies with endophytes in
which the ergot alkaloid pathway was truncated at different steps support the hypothesis
that inefficiency in the ergot alkaloid pathway is beneficial (Panaccione, 2005;
Panaccione et al., 2006; Potter et al., 2008). Moreover, since different stresses are
likely to be encountered by different tissues, variation of pathway efficiency by tissue
could be advantageous to the symbiotum. The plant’s basal meristem and seeds are
most vital for the fungus to defend, which may account for the high amounts of total
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detectable alkaloids in seeds and pseudostems, which protect the basal meristematic
regions. The presence of alkaloids in leaves is a possible way of the endophyte to
protect its host’s resources from grazing animals.
Recent evidence has shown that knock out of easA in A. fumigatus, results in the
accumulation of high concentrations of chanoclavine and lesser amounts of
chanoclavine aldehyde (Coyle et al., 2010). So the product of easA is required for the
formation of more complex tetracyclic ergot alkaloids, such as agroclavine, from the
simple tricyclic alkaloids such as chanoclavine in Neotyphodium sp. Lp1 (Cheng et al.,
2010; Coyle et al., 2010). Analyses of different tissues of perennial ryegrass inhabited
by Neotyphodium sp. Lp1 support previous findings that only trace quantities of
intermediates such as agroclavine, elymoclavine, lysergic acid are detected between
intermediate chanoclavine and pathway end product ergovaline (Panaccione et al.,
2003; Panaccione, 2005). This suggests that once agroclavine, the first tetracylic
intermediate, is formed, the pathway flows very efficiently and results in the production
of ergovaline. Although alkaloid and mRNA results from RNAi-mediated knock down of
easA suggest that easA strongly affects the efficiency in the flow of intermediates down
the ergot alkaloid pathway after the formation of chanoclavine, alkaloid and mRNA data
from easA overexpression analyses indicated no change in the levels of chanoclavine.
When easA is over expressed all the intermediate chanoclavine should be converted
into further downstream alkaloids. The fact that we do not see any change in levels of
chanoclavine of overexpression strains in comparison to the wild-type indicates that
when chanoclavine levels fall below the threshold value it probably results in up
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regulation of the genes upstream to easA. This upregulation could have further led to
increased chanoclavine accumulation.
Endophytes, by means of their ergot alkaloid production, impart toxic properties
to their host plants, making them less desirable as forage crops. Toxicity can be
possibly ameliorated by using endophytes with altered ergot alkaloid profiles. Symbiota
with genetically altered ergot alkaloid profiles generated by this study may be used to
differentiate the role of individual ergot alkaloids in animal toxicity and in other
endophyte associated traits. Since the endophyte is transmissible only via seeds the
generation and incorporation of agronomically desired traits conferred by genetically
modified endophytes may provide a viable strategy in controlling animal toxicity.
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FIGURE LEGENDS
Figure 1: Condensed version of the ergot alkaloid biosynthetic pathway of
Neotyphodium sp. Lp1. Multiple arrows indicate omitted intermediates.

Figure 2: Schematic representation of easA RNAi and overexpression constructs. (A)
Map of the RNAi plasmid construct containing the easA sequence under the control of
the toxA promoter from Pyrenophora tritici-repentis and the trpC terminator from A.
nidulans. The elements of the plasmid are represented by open and shaded boxes
which are, respectively, the coding regions of easA, artificially engineered intron
(sequence indicated by lowercase letters) between the complementary easA coding
sequences (represented by uppercase letters). The underlined sequence indicates the
BsrGI recognition sequence introduced for cloning. (B) Map of the easA overexpression
plasmid construct containing the easA sequence driven by the gigA promoter derived
from Neotyphodium sp. Lp1.

Figure 3: Total ergot alkaloid levels in pseudostem, center leaf, outer leaf, flag leaf,
inflorescence and dough stage seeds of the perennial ryegrass infected with wild-type
Neotyphodium sp. Lp1 (n=3).

Figure 4: Accumulation of indicated ergot alkaloids in pseudostem, center leaf, outer
leaf, flag leaf, inflorescence and dough stage seeds of the perennial ryegrass plant
infected with wild-type Neotyphodium sp. Lp1 (n=3).
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Figure 5: Levels of indicated ergot alkaloids in pseudostem tissue of perennial ryegrass
infected with (A) easA RNAi-1, (B) easA RNAi-2 and (C) easA RNAi-3 transformant
Neotyphodium sp. Lp1 strains. Asterisks represent significant differences (P< 0.05)
between transformant and wild type (n=3).

Figure 6: Levels of indicated ergot alkaloids in leaf tissue of perennial ryegrass
infected with (A) easA RNAi-1, (B) easA RNAi-2 and (C) easA RNAi-3 transformant
Neotyphodium sp. Lp1 strains. Asterisks represent significant differences (P< 0.05)
between transformant and wild type.

Figure 7: Levels of indicated ergot alkaloids in pseudostem tissue of perennial
ryegrass infected with (A) easA overexpression -1, (B) easA overexpression -2 and (C)
easA overexpression -3 transformant Neotyphodium sp. Lp1 strains. Asterisks
represent significant differences (P< 0.05) between transformant and wild type (n=3).

Figure 8: Levels of indicated ergot alkaloids in leaf tissue of perennial ryegrass infected
with (A) easA overexpression -1, (B) easA overexpression-2 and (C) easA
overexpression-3 transformant Neotyphodium sp. Lp1 strains. Asterisks represent
significant differences (P< 0.05) between transformant and wild type (n=3).
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Table 1: Primers used in this study. F, forward primer; R, reverse primer.
Primer
Sequence 5'- 3'
name
RNAi-1F
CACCTCGAGGCTGTGTTTGCGCATCATTATGTC
RNAi-2R
CACTGTACAAATAGTCATACCCGATGTATGAGTTGATCTCATC
G
RNAi-3F
CACTGTACAGTTAGAACAAAGAATGAAATTAACGTATAACGAT
AGCCGATGTATGAGTTGATCTCATCG
RNAi-4R
GATCTATGCGGCCGCGGCTGTGTTTGCGCATCATTATGTC
toxA-F
TAGTGGGGTACCGGAATCCATGGAGGAGT
toxA-R
GATAGAACTCGAGCCTATATTCATTCATT
trpC-F
TGACGTGAGCTCTAGTGATTTAATAGCTCCAT
trpC-R
GATAGAGAGCTCCATTCACTAGGCAACCATGGTTAC
easAO-1-F CACTGTACAGCTGTGTTTGCGCATCATTATGTC
easAO-1-R GACGCGGCCGCCCTTGGGTTATCCTACCGACTACA
Nc25-F
Nc25-R
hyg-F
hyg-R

	
  

GTACTCGAGCTACTGCGTATAGAGTAGTGAGTA
CACTGTACAGGTGAACGTTTTTGACTGTTG
CCGTGGAGGTAATAATTGA
CGAAGAACGTTTTCCAATGA
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FIGURE 3.
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FIGURE 4.
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FIGURE 5.
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FIGURE 6.
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FIGURE 7.
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FIGURE 8.
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APPENDIX-1
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Real-time PCR analysis of grass symbiota
containing wild-type and transformed
Neotyphodium lolii × Epichloë typhina isolate
Lp1 (Neotyphodium sp. Lp1).

Original data from research by Dr. Simona Florea, University of Kentucky
Summarized by Prashanthi Mulinti
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INTRODUCTION
Dr. Florea performed real-time PCR analysis on the same pseudostem tissues that
were analyzed for ergot alkaloids in Chapter 2, to check the accumulation of mRNA
from certain ergot alkaloid cluster genes. I am summarizing Dr. Florea’s findings here,
because comparison of alkaloid and mRNA data will provide important information
about factors affecting flow of intermediates through the ergot alkaloid pathway.

MATERIALS AND METHODS
Tissue collection and RNA isolation
Pseudostems were collected from plants inoculated with Neotyphodium sp. Lp1 and
rapidly frozen in liquid nitrogen. Total RNA was isolated from 100 mg of each sample by
application of the RNeasy Plant Mini kit (Qiagen, Valencia, CA, USA) according to
manufacturer’s instructions. The RNA integrity was determined by agarose gel
electrophoresis.
DNase treatment and Reverse transcription
The total RNA was treated for removal of contaminating DNA with DNA-free kit
(Ambion, Austin, TX) and quantified by Qubit fluorometer (Invitrogen, USA) following the
recommendations of Quant-iT RNA Assay Kit. The cDNA was synthesized from 1 µg
RNA by application of the High-Capacity cDNA Reverse Transcription Kit (Applied
Biosystems) according to manufacturer’s instructions.

Real-Time quantitative PCR (RT-qPCR)

	
  

86	
  

The RT-qPCR assays were performed in 7900 HT Fast Real-Time PCR System
(Applied Biosystems) employing SYBR green detection. The RT-qPCRs were
conducted in 96-microwell plates, where each sample-gene combination was loaded in
triplicate. The reactions contained 5 µL of cDNA, 10 µL SYBR mix and 0.4 µM of each
primer in a final reaction volume of 20 µL. The primers for the target genes (dmaW,
easA, cloA, lpsA, easC, and easD) and the reference genes (tefA and EF1-α) were
generated by IDT (Coraville, IA, USA) and are listed in Table 1. The relative
metabolically active fungal biomass in different tissues was estimated by measuring the
mRNA level of fungal gene tefA (encoding translation elongation factor 1- α) with the
plant translation elongation factor 1-α (EF1-α) mRNA as reference. Expression of all
tested genes was calculated with the relative comparative Ct method (ΔΔCt =
normalized Ct as ΔCt – calibrator, where ΔCt = Ct of target gene – Ct of tefA, and
calibrator = median of ΔCt), using tefA as the reference gene for normalization. For
each gene, the relative level of gene expression was then converted into fold-difference
relative to the calibrator as 2−ΔΔCt (Livak and Schmittgen 2001).

RESULTS AND DISCUSSION
Real-time data indicated that although there is ubiquitous expression of all pathway
genes tested in all the tissues, significant differences in mRNA abundance of different
pathway genes was detected among different tissues (P<0.05) (Fig. 1). The high mRNA
abundance of lpsA, which is required for the formation of pathway end product
ergovaline (Panaccione et al., 2001), in pseudostem and center leaf is consistent with
the higher accumulation of ergovaline in these tissues. The high mRNA levels of cloA,
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which catalyzes the formation of lysergic acid from elymoclavine (Haarmann et al.,
2006), in dough stage seeds is consistent with higher accumulation of end products of
the pathway. Within an individual tissue there was no significant difference in the
abundance of mRNA of different pathway genes indicating that factors other than
mRNA abundance contribute to the accumulation of alkaloids in different tissues.
RT-PCR analysis also was performed on pseudostems from plants infected with
easA RNAi and overexpression transformants, to measure accumulation of easA
mRNA. Quantities of transcripts of dmaW also were determined, since dmaW controls
the first determinant step of the ergot pathway (Wang et al., 2004). Similarly, mRNA of
tefA, which encodes translation elongation factor 1-α, was measured to estimate the
relative amount of metabolically active fungal biomass among the tissues. RT-PCR
analysis was performed on plants representing three different easA RNAi
Neotyphodium sp. Lp1 transformants (easA-RNAi-1, easA-RNAi-2 and easA-RNAi-3)
and three easA overexpression Neotyphodium sp. Lp1 strains (easA-overexpression-1,
easA-overexpression-2 and easA-overexpression-3). The data are depicted in Figures 2
and 3 respectively.
Data from RT-PCR analysis of easA gene in RNAi 1 and 2 transformants indicate
that the lower levels of mRNA of easA resulted in lower accumulation of pathway end
product ergovaline and higher accumulation of chanoclavine and shunt product 6,7secolysergine (Fig. 2A and B). In overexpression transformants 1 and 2, the high
quantities of easA mRNA are consistent with the observed differences in ergot alkaloid
accumulation in these transformants (Fig. 3A and B). The concentrations of tefA mRNA
indicated that there was no significant difference in fungal biomass between the
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transformants and wild type (Fig 2 and 3). Data from easA-RNAi-3 and easAoverexpression-3 strains did not show any significant difference in the expression of the
ergot pathway genes when compared to wild type, which supports the lack of difference
observed in the alkaloid data (Fig. 2C and 3C).

CONCLUSION
Collectively, results from this study demonstrate that the ergot pathway inefficiency
which results in differential accumulation of ergot alkaloids in different tissues of the
grass plant is strictly regulated and is atleast in part under the control of tightly regulated
expression of ergot pathway genes. RT-PCR analysis of easA gene indicates that the
observed variation in the ergot alkaloid profile of RNAi and overexpression
transformants coincides with the change in mRNA abundance of easA gene.
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FIGURE LEGENDS
Figure 1: Abundance of mRNA from indicated ergot alkaloid genes in pseudostem,
center leaf, outer leaf, flag leaf, inflorescence and dough stage seeds (in the order
represented by graphical form) of perennial ryegrass infected with wild-type
Neotyphodium sp. Lp1 (n=3). Expression of all tested genes was calculated with the
relative comparative Ct method using tefA as the reference gene for normalization.

Figure 2: Abundance of mRNA from indicated genes in pseudostem of perennial
ryegrass plant infected with Neotyphodium sp. Lp1 RNAi-1, 2 and 3 transformant strains
(A-C respectively). Expression of all tested genes was calculated with the relative
comparative Ct method using tefA as the reference gene for normalization.

Figure 3: Abundance of mRNA from indicated genes in pseudostem of perennial
ryegrass plant infected with Neotyphodium sp. Lp1 overexpression-1, 2 and 3
transformant strains (A-C respectively) (n=3). Expression of all tested genes was
calculated with the relative comparative Ct method using tefA as the reference gene for
normalization.
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Table1: Primers used in real-time quantitative PCR assays
Primer name

Sequence

TQM_tefA_F2

TGC GCT ATC CTG ATT ATC GCT GCT

TQM_tefa_R2

TTG ATG GCA ACG ATG AGC TGC TTG

dmaW_RT(f)

AGC CAG GCA TAG ACC TTC AA

dmaW_RT(r)

GAG CCA AAC ACA AGC TCC TG

Lolium EF1-fwd

TTG AGA GGT CCA CCA ACC TTG ACT

Lolium EF1-rev

GCA CAG TTC CAA TGC CAC CAA TCT

easA_RT2_f

GTC GTC CAT GGT GCC CAT TC

easA_RT2_r

TCG AAC TCC ACG GTG CCA AT

cloA_RT1_f

AGG GAC GAT TTT CCT CAC GCT

cloA_RT1_r

GAT GTG AAC ATG GTT TGG GCC

easC_RT2_f

CAA GGG CAT GGC AGT CAA GTT

easC_RT2_r

GGC CAA CAT ACG CAC TCA TAC

lpsA_RT2_f

CCA GCA ATG CCT TGT ATG CAG T

lpsA_RT2_r

ACG TCG CCT GTA GCT CTC TCA T

easD_RT2_f

AGT GCC GTC AAC AAG TGG TT

easD_RT2_r

ACT GGC CAC GTT GAC GAT ACT
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FIGURE 2.
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FIGURE 3.
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SUMMARY
I studied the two fungi, Aspergillus fumigatus and Neotyphodium sp. Lp1, in order to
investigate potential mechanisms affecting accumulation and transition of alkaloids
down the ergot alkaloid pathway. Each fungus provides advantages for addressing
different questions related to ergot pathway inefficiency.

Aspergillus fumigatus provides the advantage of having distinct cell types,
enabling me to study potential differences in the expression of different ergot alkaloid
pathway genes among these cell types. Previous results had demonstrated that ergot
alkaloids accumulate in or on conidia (Panaccione and Coyle, 2005; Coyle et al., 2007);
however, results from studies of wild type and mutant A. fumigatus demonstrated that
ergot alkaloids are produced in other cell types that constitute a developing
conidiophore. Furthermore, ergot alkaloid profiles from isolated mature conidia and
preparations that contained all cell types differed significantly, indicating cell-type
specific differences in ergot alkaloid accumulation. GFP expression studies of different
ergot alkaloid genes showed that these cell specific differences in alkaloid accumulation
are not due to qualitative but rather quantitative cell-type specific differences in the
expression of individual pathway genes.

Neotyphodium sp. Lp1, an endophyte of perennial rye grass accumulates
different profile of ergot alkaloids in comparison to A. fumigatus and also serves as a
good model system to study the pathway inefficiency at tissue specific level of the host
plant. I found that ergot alkaloid pathway efficiency varied in different tissues. My data,
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considered along with data provided by S. Florea and C. Schardl (University of
Kentucky) indicate that relative mRNA abundance of different ergot alkaloid pathway
genes was a significant factor in the different ergot alkaloid profiles observed among
different tissues. My attempts to genetically modify pathway efficiency by knocking
down and overexpressing easA changed the ergot alkaloid profile of Neotyphodium sp.
Lp1. RNAi mediated knock down of easA resulted in higher accumulation of the
pathway intermediate chanoclavine and shunt product 6,7-secolysergine and lower
accumulation of pathway end product ergovaline. In contrast, overexpression of easA
resulted in higher accumulation of ergovaline and no significant change in the levels of
pathway intermediates or shunt products. Therefore, in Neotyphodium sp. Lp1, the
abundance of easA mRNA has a significant role in controlling the efficiency in the flow
of intermediates down the ergot alkaloid pathway.
This research has demonstrated potential mechanisms involved in the control of
ergot alkaloid pathway efficiency and also has developed strategies in controlling
pathway efficiency. Manipulation of endophyte ergot alkaloid profiles may have utility in
studies of the effects of specific alkaloids in animal toxicosis or in protecting grasses
from insects.
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